Cargando…

Clonal competition in BcrAbl-driven leukemia: how transplantations can accelerate clonal conversion

BACKGROUND: Clonal competition in cancer describes the process in which the progeny of a cell clone supersedes or succumbs to other competing clones due to differences in their functional characteristics, mostly based on subsequently acquired mutations. Even though the patterns of those mutations ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cornils, Kerstin, Thielecke, Lars, Winkelmann, Doreen, Aranyossy, Tim, Lesche, Mathias, Dahl, Andreas, Roeder, Ingo, Fehse, Boris, Glauche, Ingmar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512731/ https://www.ncbi.nlm.nih.gov/pubmed/28709463 http://dx.doi.org/10.1186/s12943-017-0668-x

Ejemplares similares

Limitations and challenges of genetic barcode quantification
por: Thielecke, Lars, et al.
Publicado: (2017)

Multiplexing clonality: combining RGB marking and genetic barcoding
por: Cornils, Kerstin, et al.
Publicado: (2014)

Model Based Analysis of Clonal Developments Allows for Early Detection of Monoclonal Conversion and Leukemia
por: Baldow, Christoph, et al.
Publicado: (2016)

The Reconstitution Dynamics of Cultivated Hematopoietic Stem Cells and Progenitors Is Independent of Age
por: Gotzhein, Frauke, et al.
Publicado: (2022)

A Cell-Based Assay for Measuring Endogenous BcrAbl Kinase Activity and Inhibitor Resistance
por: Ouellette, Steven B., et al.
Publicado: (2016)

Reduced adhesion of aged intestinal stem cells contributes to an accelerated clonal drift
por: Hageb, Ali, et al.
Publicado: (2022)

S114: OUTCOME OF OLDER PATIENTS (>55 YRS) WITH NEWLY DIAGNOSED PH/BCR:ABL POSITIVE ALL PROSPECTIVELY TREATED ACCORDING TO PEDIATRIC-BASED, AGE-ADAPTED GMALL PROTOCOLS
por: Lang, Fabian, et al.
Publicado: (2023)

Nilotinib based pharmacophore models for BCRABL
por: Sabitha, Kesavan
Publicado: (2012)

Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia
por: Zhang, Zhanglin, et al.
Publicado: (2019)

Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing
por: Cavelier, Lucia, et al.
Publicado: (2015)

Stem Cell Proliferation and Quiescence—Two Sides of the Same Coin
por: Glauche, Ingmar, et al.
Publicado: (2009)

Continuous therapy response references for BCR::ABL1 monitoring in pediatric chronic myeloid leukemia
por: Volz, Christian, et al.
Publicado: (2023)

Clonal evolution of AML1-ETO coexisting with BCR-ABL and additional chromosome abnormalities in a blastic transformation of chronic myeloid leukemia
por: Ma, Cheng-Cheng, et al.
Publicado: (2020)

Nanog Variability and Pluripotency Regulation of Embryonic Stem Cells - Insights from a Mathematical Model Analysis
por: Glauche, Ingmar, et al.
Publicado: (2010)

Clonal reconstruction from co-occurrence of vector integration sites accurately quantifies expanding clones in vivo
por: Wagner, Sebastian, et al.
Publicado: (2022)

PB1767: CHALLENGES IN MACHINE LEARNING-BASED DETECTION OF MEASURABLE RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Thielecke, Lars, et al.
Publicado: (2023)

Multi-color RGB marking enables clonality assessment of liver tumors in a murine xenograft model
por: Thomaschewski, Michael, et al.
Publicado: (2017)

Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy
por: Salmon, Matthew, et al.
Publicado: (2022)

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
por: Mian, Afsar Ali, et al.
Publicado: (2012)

Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy
por: Haaß, Wiltrud, et al.
Publicado: (2015)

Targeting BCR-ABL(+) stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex
por: Chen, Min, et al.
Publicado: (2017)

Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: a simulation study based on phase III trial data
por: Fassoni, Artur C., et al.
Publicado: (2018)

BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
por: Sharma, Nitesh, et al.
Publicado: (2015)

Pterostilbene downregulates BCR/ABL and induces apoptosis of T315I-mutated BCR/ABL-positive leukemic cells
por: Kawakami, Shohei, et al.
Publicado: (2022)

A Model-Based Analysis of Culture-Dependent Phenotypes of mESCs
por: Herberg, Maria, et al.
Publicado: (2014)

MAGPIE: Simplifying access and execution of computational models in the life sciences
por: Baldow, Christoph, et al.
Publicado: (2017)

Defining Clonal Color in Fluorescent Multi-Clonal Tracking
por: Wu, Juwell W., et al.
Publicado: (2016)

Competitive exclusion of clonal subpopulations in heterogeneous tumours after stromal injury.
por: Leith, J. T., et al.
Publicado: (1989)

Studies of Myc super-competition and clonal growth in Drosophila males and females
por: Svoysky, Abigail J, et al.
Publicado: (2021)

BCR: a new target in resistance mediated by BCR/ABL-315I?
por: Haberbosch, Isabella, et al.
Publicado: (2016)

The novel anticancer agent JNJ-26854165 is active in chronic myeloid leukemic cells with unmutated BCR/ABL and T315I mutant BCR/ABL through promoting proteosomal degradation of BCR/ABL proteins
por: You, Liangshun, et al.
Publicado: (2016)

The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report
por: De Benedittis, Caterina, et al.
Publicado: (2017)

Expanding the Diversity of Allosteric Bcr-Abl Inhibitors
por: Deng, Xianming, et al.
Publicado: (2010)

An In-House Method for Molecular Monitoring of BCR-ABL
por: Sercan, Hakkı Ogün, et al.
Publicado: (2012)

Depression of oncogenecity by dephosphorylating and degrading BCR-ABL
por: Gao, Miao, et al.
Publicado: (2016)

On the clonality of tumours.
por: Woodruff, M. F., et al.
Publicado: (1985)

An Invasive Clonal Plant Benefits from Clonal Integration More than a Co-Occurring Native Plant in Nutrient-Patchy and Competitive Environments
por: You, Wenhua, et al.
Publicado: (2014)

AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells
por: Zhou, Liang L., et al.
Publicado: (2008)

The HSP90 inhibitor KW-2478 depletes the malignancy of BCR/ABL and overcomes the imatinib-resistance caused by BCR/ABL amplification
por: Zeng, Dachuan, et al.
Publicado: (2022)

Idiopathic hypereosinophilia is clonal disorder? Clonality identified by targeted sequencing
por: Lee, Jee-Soo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bm4vnlhj7g44r6mqop0t85o6pm